Literature DB >> 15002730

Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes.

Emilio Galván1, María Sitges.   

Abstract

The participation of voltage-sensitive Na+ channels (VSSC) on the changes on internal (i) Na+, K+, Ca2+, and on DA, Glu, and GABA release caused by different concentrations of 4-AP was investigated in striatum synaptosomes. TTX, which abolished the increase in Na(i) (as determined with SBFI), induced by 0.1 mM 4-AP only inhibited by 30% the rise in Na(i) induced by 1 mM 4-AP. One millimolar 4-AP markedly decreased the fluorescence of the K+ indicator dye PBFI but 0.1 mM 4-AP did not. Like 1 mM 4-AP, ouabain decreased PBFI fluorescence and increased a considerable fraction of Na(i) in a TTX-insensitive manner. In contrast with the different TTX sensitivity of the rise in Na(i) induced by 0.1 and 1 mM 4-AP, the rise in Ca(i) (as determined with fura-2) induced by the two concentrations of 4-AP was markedly inhibited by TTX, as well as by omega-agatoxin in combination with omega-conotoxin GVIA, indicating that only the TTX-sensitive fraction of the rise in Na(i) induced by 4-AP is linked with the activation of presynaptic Ca2+ channels. It is concluded that the TTX-sensitive fraction of neurotransmitter release evoked by 4-AP is released by exocytosis, and the TTX insensitive fraction involves reversal of the neurotransmitters transporters. This contrasts with the exocytosis evoked by high K+ that is unchanged by TTX and with the neurotransmitter-transporter-mediated release evoked by veratridine, which is highly TTX sensitive and does not require activation of Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15002730     DOI: 10.1023/b:nere.0000013737.17288.ce

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  Calcium channels coupled to glutamate release identified by omega-Aga-IVA.

Authors:  T J Turner; M E Adams; K Dunlap
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

2.  Study on the possible involvement of protein kinases in the modulation of brain presynaptic sodium channels; comparison with calcium channels.

Authors:  M Sitges; F Peña; L M Chiu; A Guarneros
Journal:  Neurochem Int       Date:  1998-02       Impact factor: 3.921

3.  Effects of external pH variations on brain presynaptic sodium and calcium channels; repercussion on the evoked release of amino acid neurotransmitters.

Authors:  M Sitges; R M Rodríguez
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

Review 4.  Release of glutamate, aspartate, and gamma-aminobutyric acid from isolated nerve terminals.

Authors:  D G Nicholls
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

5.  omega-Aga IVA selectively inhibits the calcium-dependent fraction of the evoked release of [3H]GABA from synaptosomes.

Authors:  M Sitges; L M Chiu
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

6.  Effect of organic and inorganic calcium channel blockers on gamma-amino-n-butyric acid release induced by monensin and veratrine in the absence of external calcium.

Authors:  M Sitges
Journal:  J Neurochem       Date:  1989-08       Impact factor: 5.372

7.  Mechanism of aminopyridine-induced release of [3H]dopamine from rat brain synaptosomes.

Authors:  H W Scheer; P A Lavoie
Journal:  Gen Pharmacol       Date:  1991

8.  Detection of intracellular free Na+ concentration of synaptosomes by a fluorescent indicator, Na(+)-binding benzofuran isophthalate: the effect of veratridine, ouabain, and alpha-latrotoxin.

Authors:  Z Deri; V Adam-Vizi
Journal:  J Neurochem       Date:  1993-09       Impact factor: 5.372

9.  4-Aminobutyrate can be released exocytotically from guinea-pig cerebral cortical synaptosomes.

Authors:  T S Sihra; D G Nicholls
Journal:  J Neurochem       Date:  1987-07       Impact factor: 5.372

10.  (+/-)-Kavain inhibits veratridine-activated voltage-dependent Na(+)-channels in synaptosomes prepared from rat cerebral cortex.

Authors:  J Gleitz; A Beile; T Peters
Journal:  Neuropharmacology       Date:  1995-09       Impact factor: 5.250

View more
  6 in total

1.  Presynaptic inhibition of the release of multiple major central nervous system neurotransmitter types by the inhaled anaesthetic isoflurane.

Authors:  R I Westphalen; K M Desai; H C Hemmings
Journal:  Br J Anaesth       Date:  2012-12-04       Impact factor: 9.166

2.  PKCζ-NADPH Oxidase-PKCα Dependent Kv1.5 Phosphorylation by Endothelin-1 Modulates Nav1.5-NCX1-Cav1.2 Axis in Stimulating Ca2+ Level in Caveolae of Pulmonary Artery Smooth Muscle Cells.

Authors:  Jaganmay Sarkar; Tapati Chakraborti; Pijush Kanti Pramanik; Priyanka Ghosh; Amritlal Mandal; Sajal Chakraborti
Journal:  Cell Biochem Biophys       Date:  2020-10-23       Impact factor: 2.194

3.  Effects of Levetiracetam, Carbamazepine, Phenytoin, Valproate, Lamotrigine, Oxcarbazepine, Topiramate, Vinpocetine and Sertraline on Presynaptic Hippocampal Na(+) and Ca(2+) Channels Permeability.

Authors:  María Sitges; Luz María Chiu; Ronald C Reed
Journal:  Neurochem Res       Date:  2015-11-05       Impact factor: 3.996

4.  Effect of the Anti-depressant Sertraline, the Novel Anti-seizure Drug Vinpocetine and Several Conventional Antiepileptic Drugs on the Epileptiform EEG Activity Induced by 4-Aminopyridine.

Authors:  Maria Sitges; Blanca Irene Aldana; Ronald Charles Reed
Journal:  Neurochem Res       Date:  2016-01-30       Impact factor: 3.996

5.  Sertraline reduces IL-1β and TNF-α mRNA expression and overcomes their rise induced by seizures in the rat hippocampus.

Authors:  María Sitges; Carlos D Gómez; Blanca I Aldana
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

6.  Toxicological evaluation of convulsant and anticonvulsant drugs in human induced pluripotent stem cell-derived cortical neuronal networks using an MEA system.

Authors:  A Odawara; N Matsuda; Y Ishibashi; R Yokoi; I Suzuki
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.